دورية أكاديمية

Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

التفاصيل البيبلوغرافية
العنوان: Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
المؤلفون: Grimm, Sabine E.Aff1, Fayter, Debra, Ramaekers, Bram L. T., Petersohn, Svenja, Riemsma, Rob, Armstrong, Nigel, Pouwels, Xavier, Witlox, Willem, Noake, Caro, Worthy, Gillian, Kleijnen, Jos, Joore, Manuela A.
المصدر: PharmacoEconomics. 37(10):1195-1207
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:11707690
11792027
DOI:10.1007/s40273-019-00792-7